4//SEC Filing
Templeman Blaine 4
Accession 0001567619-18-006813
CIK 0001435049other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 7:58 PM ET
Size
5.4 KB
Accession
0001567619-18-006813
Insider Transaction Report
Form 4
Templeman Blaine
Executive VP, General Counsel
Transactions
- Sale
Common Stock
2018-11-20$2.91/sh−843$2,453→ 131,119 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2018.
- [F2]The shares sold were originally acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2018.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.87 to $2.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
ADURO BIOTECH, INC.
CIK 0001435049
Entity typeother
Related Parties
1- filerCIK 0001653641
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 7:58 PM ET
- Size
- 5.4 KB